Tag:
Sanofi Pasteur
Latest Headlines
Latest Headlines
Study: Dengue virus research needs to focus on people, not mice
There are no dengue virus vaccines so far, but new research from the University of North Carolina and Vanderbilt University could help speed vaccines to the market.
Groups urge FTC to investigate vaccine 'bundling'
Several watchdog groups are calling upon the Federal Trade Commission to investigate Sanofi Pasteur and Merck for allegedly forcing doctors to buy bundled vaccines.
Scientists balk as U.S. gov't pushes limits to bird flu discourse
Scientists are crying foul about U.S. government efforts to seek publication restrictions on research involved in building variations of the H5N1 bird flu virus. Others are OK with the move,...
Sanofi Pasteur, CureVac ink wide-ranging vaccine deal
Sanofi Pasteur and Germany's CureVac have signed a €150 million deal to develop and apply the latter's RNActive technology platform to the development of vaccines against several infectious
Sanofi Pasteur marshals biotech forces behind €150M vax program
Germany's CureVac is joining hands with Sanofi Pasteur on a €150 million deal to develop new vaccines against infectious diseases. In addition, the platform mRNA vaccine company will join forces
Sanofi aims for acne vaccine in new pact
Lured by the $3 billion acne treatment market, Sanofi Pasteur has inked a collaboration deal with with the University of California, San Diego to develop an immunological approach to fighting the
Sanofi tackles $3B acne market with UC San Diego pact
Acne may not rank up there with, say, cancer in the area of unmet medical needs. But with a $3 billion market at stake, it's serious enough to grab the attention of Sanofi Pasteur , which today
Sanofi taps Leukocare for vaccine stabilization
Sanofi Pasteur says it will examine Leukocare's Stabilizing and Protecting Solutions technology to see whether the platform could help the vaccine developer improve the shelf-life of its vaccines,
Sanofi's dengue fever vax progresses in Thai trial
Reuters reports today that Sanofi's experimental vaccine for dengue fever, the most advanced its kind, is making progress in a Thai trial. The vaccine, which is on track to be available in 2014, is
GSK, Merck lead vaccine price cuts for GAVI
Vaccine makers are pledging big price cuts for developing nations as officials gather to determine how they can pay to protect children around the world from disease. GlaxoSmithKline has promised to
